Clinical Trial Update: A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma [Phase 3]

View source ↗

Summary

A Phase 3, multicenter randomized double-blind, placebo-controlled study evaluating the efficacy and safety of SHR-1703 in eosinophilic asthma is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SHR-1703

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Asthma With Eosinophilic Phenotype | Phase 3 | Status: RECRUITING